Status
Conditions
Treatments
About
This study will evaluate the performance of the CorPath GRX System in Robotic Primary PCI (RPPCI) in the treatment of ST-elevated myocardial infarction (STEMI).
Full description
This is a prospective, post-market, single-arm, multi-center, observational study to evaluate the performance of the CorPath GRX System during robotic-PCI for acute ST elevation myocardial infarction (STEMI).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Cardiogenic shock
3 participants in 1 patient group
Loading...
Central trial contact
John Van Vleet, MS; Tina Ridgeway, BS, RN
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal